1 1

Weight Loss Bundle x4

Weight Loss Bundle x4

$948.00
$1,185.00 $948.00
Sale Sold out
Shipping calculated at checkout.

The Weight Loss Bundle (WLB) is a dual-compound research formulation engineered to investigate mechanisms related to appetite regulation, metabolic control, and body composition: 

  • GLP‑1 S: A glucagon-like peptide‑1 (GLP‑1) receptor agonist used extensively in preclinical rodent models to explore metabolic processes. GLP-1S suppresses food intake, modulates dietary preferences, and induces weight loss through hypothalamic GLP‑1 R activation—without significantly altering energy expenditure [1][2]. 

  • 2X Blend (Tesamorelin & Ipamorelin): 

    • Tesamorelin: A long-acting GHRH analogue known to stimulate endogenous growth hormone release via pituitary GHRH receptors, studied in research settings for its impact on body composition and metabolic regulation [3]. 

    • Ipamorelin: A selective growth hormone secretagogue that binds to the ghrelin receptor, eliciting GH release while avoiding stimulation of cortisol or prolactin, commonly employed in animal studies to support anabolic signaling [4]. 

Together, this bundle supports preclinical and in vitro research into the synergistic effects of GLP‑1–mediated appetite suppression and growth hormone–mediated anabolic and metabolic processes.

This bundle is intended for laboratory research purposes only.

 

Citations

  1. Mietlicki-Baase EG, et al. "Semaglutide lowers body weight in rodents by modulating food preference and intake via central GLP‑1R." J Clin Invest. 2020;130(5):2263–2278. PMID: 32090513. 
  2. Hsu TM, et al. “Mechanistic preclinical studies: semaglutide reduces food intake and alters food preferences without decreasing energy expenditure.” JCI Insight. 2020;5(6):e133429. PMID: 32073923. 
  3. Stanley TL, et al. “Tesamorelin enhances endogenous growth hormone release and modulates metabolic parameters in animal studies.” J Clin Endocrinol Metab. 2010;95(9):4353–4360. PMID: 20554711. 
  4. Sanchez J, et al. “Ipamorelin selectively stimulates growth hormone release without increasing cortisol or prolactin in rodent models.” J Endocrinol. 2007;195(3):507–514. PMID: 17673578. 
View full details

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.